Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;16(11):1243-54.
doi: 10.1007/s00520-008-0420-6. Epub 2008 Mar 6.

The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)

Margaret F Bevans  1 , Sandra A Mitchell, Susan Marden
Affiliations

The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)

Margaret F Bevans et al. Support Care Cancer. 2008 Nov.

Abstract

Goals of work: Despite advances in allogeneic hematopoietic stem cell transplantation (HSCT), post-transplant complications are common, and patients' symptom experience has not been well documented.

Purpose: To characterize the symptom experience of adult patients pre-transplantation and days 0, 30, and 100 after allogeneic HSCT.

Methods: Data from 76 participants enrolled in a prospective health-related quality of life (HRQL) study were used. Symptom occurrence, distress, and clusters were determined based on the 11 symptoms of the Symptom Distress Scale (SDS).

Results: Participants were on average 40 years old (SD +/- 13.5). The majority (54%) received reduced intensity conditioning. Prevalent symptoms included fatigue (68%) and worry (68%) at baseline, appetite change (88%) at day 0, and fatigue at days 30 (90%) and 100 (81%). Participants reported the following symptoms as severely distressing: worry (16%) [baseline], insomnia (32%) [day 0], appetite change (22%) [day 30], and fatigue (11%) [day 100]. The total SDS score was highest at day 0 (M = 26.6 +/- 7.6) when the highest number of symptoms were reported [median = 8 (1-11)]. Symptoms formed clusters comprised of fatigue, appearance change, and worry at baseline, and fatigue, insomnia, and bowel changes at days 0 and 30. Compared to those with low symptom distress, participants with moderate/severe symptom distress reported poorer HRQL.

Conclusion: Allogeneic HSCT patients present for transplantation with low symptom distress yet experience multiple symptoms and high symptom distress after HSCT conditioning. Understanding the symptom experience of allogeneic HSCT patients can guide management strategies and improve HRQL.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Baseline symptom prevalence and distress Note: n = 74, incomplete survey responses n = 2; Baseline symptom count: Median 5 (range 0-11); Symptom distress (mean±SD) score: 21.2 ± 5.9.
Figure 2
Figure 2
Day 0 symptom prevalence and distress Note: n = 73; Day 0 symptom count: Median 8 (range 1-11); Symptom distress (mean ±SD) score: 26.6 ± 7.6.
Figure 3
Figure 3
Day 30 symptom prevalence and distress Note: n = 67; Day 30 symptom count: Median 7 (range 0-11); Symptom distress (mean ±SD) score: 24.9 ± 7.3.
Figure 4
Figure 4
Day 100 symptom prevalence and distress Note: n = 57; Day 100 symptom count: Median 5 (range 0-11); Symptom distress (mean ±SD) score: 21.6 ± 6.2.
Figure 5
Figure 5
Relationships (rs) Between Symptoms in the Most Prevalent Symptom Clusters at Baseline and Days 0 and 30 after Allogeneic HSCT Note: rs = Spearman Rho Correlation an= 74, bn = 73, cn = 67
See this image and copyright information in PMC

References

    1. Moya R, Espigado I, Parody R, Carmona M, Marquez F, De Blas JM. Evaluation of readmissions in hematopoietic stem cell transplant recipients. Transplant Proc. 2006;38(8):2591–2592. - PubMed
    1. Papadopoulos EB, Jakubowski AA. Novel approaches in allogeneic stem cell transplantation. Curr Oncol Rep. 2006;8(5):325–336. - PubMed
    1. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med. 2002;162(14):1558–1566. - PubMed
    1. Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, et al. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35(1):77–83. - PubMed
    1. Heinonen H, Volin L, Zevon MA, Uutela A, Barrick C, Ruutu T. Stress among allogeneic bone marrow transplantation patients. Patient Educ Couns. 2005;56(1):62–71. - PubMed

MeSH terms